MAPT and Alzheimer disease: Meanwhile, Cbx co-treatment significantly suppressed the mRNA and protein expression levels of APP, Tau, and BACE1 in the brains of AD model animals, suggesting that Cbx is important for combating the pathological progression of AD (Sharma et al., 2020).